Literature DB >> 13481046

Sarcoma in Paget's disease of bone.

C A PORRETTA, D C DAHLIN, J M JANES.   

Abstract

Entities:  

Keywords:  OSTEITIS DEFORMANS/complications; SARCOMA, OSTEOGENIC

Mesh：

Year:  1957        PMID： 13481046

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  18 in total

1.  Unilateral sclerosis of upper femur.

Authors:  A Kumar; M Shoaib
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

2.  The management of benign bone lesions.

Authors:  T M Moore; J P Harvey
Journal:  West J Med       Date:  1976-02

3.  Degeneration of Paget's disease into sarcoma: clinical and therapeutic influencing factors.

Authors:  Alessandro Zati; Teresa Wanda Bilotta
Journal:  Chir Organi Mov       Date:  2008-04-12

4.  Case report 438: Osteolytic phase of Paget disease affecting the ulna in case 1 and the humerus in case 2.

Authors:  M L Mitchell; L V Ackerman; A Tsutsumi
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

5.  [Sarcomatous transformation in Paget's disease (author's transl)].

Authors:  L Zichner
Journal:  Langenbecks Arch Chir       Date:  1974

6.  [The operative treatment of the spontaneous fractures (author's transl)].

Authors:  K Walcher; W Dorn
Journal:  Arch Orthop Unfallchir       Date:  1973

7.  Sarcomatous degeneration of Paget disease in the skull.

Authors:  C Miller; V M Rao
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

Review 8.  Premalignant conditions of bone.

Authors:  Andrew Horvai; K Krishnan Unni
Journal:  J Orthop Sci       Date:  2006-07       Impact factor: 1.601

9.  Sclerosing osteogenic sarcomatosis.

Authors:  L WOLMAN
Journal:  J Clin Pathol       Date:  1961-03       Impact factor: 3.411

10.  Sarcomatous degeneration in Paget's bone disease.

Authors:  P Seret; M F Basle; A Rebel; J C Renier; J P Saint-Andre; G Bertrans; M Audran
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.